Yahoo
JonesResearch analyst Soumit Roy lowered the firm’s price target on Enliven (ELVN) to $27 from $36 and keeps a Buy rating on the shares. The company’s abstract from the Phase 1 late line chronic myeloid leukemia trial with ELVN-001 “was met with a lukewarm initial stock reaction that weakened over time,” the analyst tells investors in a research note. The firm says that even though ELVN-001 showed efficacy and safety profile inline with the September 2024 update with two-times the patient popula
Yahoo
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the first quarter ended March 31, 2025, and provided a business update, including highlights of pipeline progress.
Yahoo
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced updated, positive data from the Phase 1 ENABLE clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia (CML) in an abstract accepted for an oral presentation at the European Hematology Association (EHA) 2025 Congress taking place June 12-15 in Milan, Italy, and virtually. Update
Finnhub
Enliven Therapeutics Inc: * ENLIVEN THERAPEUTICS ANNOUNCES UPDATED POSITIVE DATA FROMPHASE1 CLINICAL TRIAL OF ELVN-001 IN CML AND ORAL PRESENTATION AT THEEHA 2025 CONGRESS ...
SeekingAlpha
Enliven Therapeutics: Awaiting Additional Trial Data
Yahoo
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the Company will present five posters at the upcoming American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois.
Double maintains 2 strategies that include ELVN - Enliven Therapeutics, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HYD | -0.08% | $3.37B | 0.32% |
UITB | 0.08% | $2.42B | 0.39% |
BSSX | -0.11% | $75.11M | 0.18% |
TOTL | -0.22% | $3.59B | 0.55% |
PZA | -0.25% | $2.89B | 0.28% |
SHM | 0.38% | $3.37B | 0.2% |
MUST | 0.40% | $403.58M | 0.23% |
FMHI | -0.41% | $757.44M | 0.7% |
IAGG | -0.50% | $7.30B | 0.07% |
UNG | -0.58% | $371.83M | 1.06% |
SPMB | 0.60% | $5.82B | 0.04% |
TFI | 0.73% | $3.15B | 0.23% |
VGLT | 0.81% | $9.57B | 0.04% |
GOVI | -0.82% | $870.08M | 0.15% |
CLIP | -0.91% | $1.50B | 0.07% |
LMBS | -0.92% | $4.97B | 0.64% |
VTIP | 0.93% | $14.78B | 0.03% |
SCHQ | 0.95% | $829.57M | 0.03% |
BILZ | -0.96% | $876.85M | 0.14% |
IBD | 0.97% | $380.12M | 0.43% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALHC | -0.03% | $2.95B | +113.16% | 0.00% |
T | 0.18% | $196.66B | +57.98% | 4.07% |
MSIF | -0.19% | $715.25M | +28.42% | 7.05% |
GIS | 0.22% | $29.79B | -23.81% | 4.42% |
DG | 0.23% | $20.45B | -36.56% | 2.55% |
PSQH | 0.24% | $89.26M | -49.87% | 0.00% |
COKE | -0.26% | $10.13B | +24.67% | 0.69% |
KDP | -0.36% | $45.55B | -1.76% | 2.70% |
ACHC | 0.37% | $2.36B | -61.52% | 0.00% |
MSEX | 0.37% | $1.02B | -1.01% | 2.34% |
CORT | 0.41% | $7.78B | +166.38% | 0.00% |
HRL | -0.57% | $16.59B | -16.43% | 3.81% |
PRPO | 0.58% | $10.84M | +15.14% | 0.00% |
HUM | -0.67% | $27.45B | -35.96% | 1.55% |
PEP | -0.71% | $180.30B | -28.19% | 4.14% |
GME | 0.74% | $12.81B | +3.47% | 0.00% |
DXCM | 0.79% | $33.59B | -35.05% | 0.00% |
PPC | -0.80% | $11.21B | +41.54% | 0.00% |
VHC | 0.89% | $34.69M | +74.89% | 0.00% |
EXC | 0.89% | $43.84B | +12.45% | 3.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 54.72% | $4.85B | 0.35% |
GNOM | 52.33% | $40.65M | 0.5% |
IWC | 50.63% | $766.88M | 0.6% |
ARKG | 49.99% | $944.78M | 0.75% |
IBB | 49.97% | $5.22B | 0.45% |
IWO | 49.83% | $11.36B | 0.24% |
KJUL | 49.10% | $113.35M | 0.79% |
VTWO | 48.15% | $12.07B | 0.07% |
IWM | 48.02% | $63.95B | 0.19% |
KOMP | 47.87% | $2.20B | 0.2% |
VBK | 47.54% | $18.33B | 0.07% |
ISCG | 47.52% | $645.00M | 0.06% |
KJAN | 47.40% | $305.13M | 0.79% |
SCHA | 47.36% | $16.91B | 0.04% |
PBE | 47.19% | $214.12M | 0.58% |
VXF | 47.05% | $21.56B | 0.05% |
QQA | 47.00% | $225.66M | 0.29% |
ARKK | 46.82% | $5.95B | 0.75% |
ESML | 46.32% | $1.81B | 0.17% |
NUSC | 46.30% | $1.14B | 0.31% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -17.12% | $45.74M | -99.96% | 0.00% |
CBOE | -15.20% | $22.95B | +20.67% | 1.12% |
K | -11.49% | $28.49B | +32.17% | 2.77% |
COR | -10.92% | $55.43B | +28.90% | 0.56% |
CME | -8.87% | $98.74B | +28.80% | 3.84% |
MO | -8.80% | $97.80B | +26.35% | 6.94% |
ED | -8.34% | $36.75B | +5.26% | 3.28% |
FATBB | -7.57% | $50.77M | -11.65% | 9.83% |
WBA | -7.38% | $9.67B | -39.04% | 6.69% |
CI | -6.43% | $82.51B | -8.96% | 1.84% |
KMB | -6.17% | $45.57B | +1.99% | 3.58% |
CHD | -6.16% | $23.29B | -11.36% | 1.23% |
KO | -5.33% | $308.23B | +13.09% | 2.75% |
UNH | -5.06% | $248.87B | -47.37% | 3.06% |
KR | -4.89% | $44.68B | +24.17% | 1.89% |
NEUE | -4.33% | $62.05M | +13.56% | 0.00% |
BNED | -4.32% | $371.19M | -38.80% | 0.00% |
HSY | -4.25% | $33.16B | -21.37% | 3.44% |
CL | -4.03% | $72.64B | -5.18% | 2.25% |
VSTA | -3.37% | $326.82M | +11.64% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -38.72% | $140.49M | 0.59% |
VIXY | -37.37% | $109.64M | 0.85% |
BTAL | -35.28% | $361.41M | 1.43% |
XONE | -20.22% | $603.24M | 0.03% |
IVOL | -19.49% | $353.94M | 1.02% |
FTSD | -18.90% | $212.46M | 0.25% |
SPTS | -18.75% | $5.76B | 0.03% |
IBTG | -16.72% | $1.88B | 0.07% |
SHYM | -15.85% | $322.93M | 0.35% |
ULST | -15.48% | $637.77M | 0.2% |
UTWO | -15.07% | $387.71M | 0.15% |
FXY | -14.26% | $838.61M | 0.4% |
VGSH | -13.35% | $22.38B | 0.03% |
SCHO | -12.11% | $10.87B | 0.03% |
IBTH | -11.67% | $1.53B | 0.07% |
BSMW | -10.81% | $102.62M | 0.18% |
IBTI | -10.81% | $995.39M | 0.07% |
LDUR | -10.03% | $849.09M | 0.5% |
AGZ | -8.79% | $607.46M | 0.2% |
IBTJ | -8.37% | $658.04M | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
APGE | 51.72% | $2.42B | -24.39% | 0.00% |
BHVN | 46.48% | $1.62B | -58.86% | 0.00% |
DNLI | 46.23% | $2.06B | -30.04% | 0.00% |
COGT | 45.61% | $543.09M | -36.14% | 0.00% |
KRYS | 45.50% | $3.77B | -20.42% | 0.00% |
ATXS | 45.36% | $225.17M | -57.69% | 0.00% |
CRNX | 44.64% | $2.92B | -39.88% | 0.00% |
BNT | 44.64% | $11.98B | +33.22% | 0.00% |
OCUL | 44.36% | $1.14B | +14.35% | 0.00% |
XNCR | 44.28% | $583.60M | -63.49% | 0.00% |
CRH | 44.11% | $66.31B | +18.04% | 0.00% |
KYMR | 44.08% | $1.95B | -15.67% | 0.00% |
ACLX | 43.54% | $3.22B | +10.72% | 0.00% |
CELC | 43.49% | $398.07M | -40.43% | 0.00% |
BN | 43.03% | $98.39B | +33.78% | 0.55% |
SXI | 42.99% | $1.87B | -10.70% | 0.82% |
EYPT | 42.90% | $393.60M | -54.31% | 0.00% |
ABEO | 42.51% | $282.55M | +25.87% | 0.00% |
RVMD | 42.19% | $7.35B | +1.15% | 0.00% |
ZYME | 41.97% | $810.02M | +22.92% | 0.00% |
Current Value
$17.731 Year Return
Current Value
$17.731 Year Return